SCHEDULE 13G/A: Sabby Entities Report Minor Stake in iBio, Inc. Through Schedule 13G Amendment

Sabby Management, LLC, Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz have jointly reported a beneficial ownership of 0.21% in iBio, Inc.'s common stock as of December 31, 2024.

Summary

• Sabby Management, LLC, Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership of iBio, Inc. (Common Stock, CUSIP 451033203).
• As of December 31, 2024, each reporting person beneficially owns 19,250 shares of iBio, Inc. common stock.
• This aggregate amount represents 0.21% of the class of iBio, Inc.'s common stock.
• The reporting persons share both voting power and dispositive power over all 19,250 shares.
• The filing indicates that the securities were not acquired or held for the purpose of changing or influencing the control of iBio, Inc.

Sentiment

Score: 5

Explanation: The document is a factual, regulatory filing (Schedule 13G) reporting beneficial ownership. It contains no qualitative information about the company's performance, strategy, or financial health, thus it is neutral in sentiment regarding iBio, Inc.'s prospects.

Future Outlook

NA

Industry Context

This Schedule 13G filing is a routine disclosure of beneficial ownership, indicating that Sabby Management, LLC and its affiliates hold a passive, non-controlling stake in iBio, Inc. Such filings are common across industries and typically do not signal major strategic shifts or competitive actions, especially for stakes below 5%.

Stakeholder Impact

• Shareholders: The filing indicates a minor, passive ownership stake by Sabby entities, which is unlikely to have a material impact on existing shareholders or the company's strategic direction due to the small percentage (0.21%).
• Management: The filing explicitly states that the shares were not acquired for the purpose of changing or influencing control, suggesting no immediate challenge to current management.

Key Dates

Keywords

iBio Inc., Schedule 13G, Beneficial Ownership, Common Stock, Sabby Management LLC, Sabby Volatility Warrant Master Fund Ltd, Hal Mintz, SEC Filing, Investment, Equity Stake